Tag Archives: russia

Business

URALCHEM Increased its Investments to $174 Million in 2013

Leave a comment

In 2013 URALCHEM’s investments in development reached $174 million, an increase of 5.5% compared to the previous year.

Moscow, Russia (March 21, 2014) — In 2013 URALCHEM‘s investments in development reached $174 million, an increase of 5.5% compared to the previous year. $84 million was spent on the implementation of investment projects, $77 million was spent on capital investments in equipment upgrades and $13 million was allocated for capitalized repairs.

The company’s plant in Kirovo-Chepetsk made the biggest contribution to the development investments – $46 million. The main areas of investment in the plant included building facilities for the production of new products, as well as reconstruction of existing facilities to increase production of mineral fertilizers and chemical products. In particular, work was continued on the project to create a new product, calcium nitrate. Another completed project was the increase in the capacity of one of the two units of nitric acid, which had originally started in 2012. Work was begun to increase the capacity of the second nitric acid unit and work continued to increase the capacity of the ammonia unit.

The investments by the “Azot” plant in Berezniki totalled $41 million. The main areas of investment were projects aimed at increasing output and reducing raw material consumption. Major work was carried out on units of production of ammonia, urea and nitric acid. $26 million was spent on the development of the plant in Perm. Most of the funds were allocated to a large-scale programme of modernization of the ammonia unit. The implementation of this project will increase production and reduce raw material consumption. The total capital investments of the plant in Voskresenks amounted to more than $13 million, which was spent on the development of new products.

The company’s major infrastructure project for the year was the completion and launch of the fertilizer handling terminal at the port of Riga in the fourth quarter of 2013. The terminal has a capacity of 2 million tonnes per year. The total investment for this project was about $78 million, $34 million of which was spent in 2013. Also in 2013, the company continued increasing the number of units in its own rolling stock, extending its life and modernizing it.

Dmitry Konyaev, CEO of URALCHEM OJSC, commented, “In 2013, URALCHEM continued to implement a long-term investment programme aimed at the technical upgrade of existing facilities. The main goal of the programme is to increase production and to improve the efficiency of technological processes, reducing rates of raw materials consumption and improving the environmental safety of production.”

PR department
URALCHEM, OJSC
Tel: +7 (495) 721 89 89
Email: pr@uralchem.com
Web: http://www.uralchem.com

URALCHEM, OJSC is one of the largest producers of nitrogen and phosphate fertilisers in Russia and the CIS with production capacities of over 2.5 million tonnes of ammonium nitrate, 2.8 million tonnes of ammonia, 0.8 million tonnes of MAP and DAP, 0.8 million tonnes of complex fertilisers and 1.2 million tonnes of urea. URALCHEM, OJSC is the second largest ammonium nitrate producer in the world and number one in Russia, the second largest producer of nitrogen fertilisers in Russia. Key production assets of URALCHEM, OJSC include Azot Branch of URALCHEM, OJSC in Berezniki, Perm Region; OJSC Minudobrenia, Perm; MFP Kirovo-Chepetsk Chemical Works, OJSC Branch in Kirovo-Chepetsk, Kirov region; Voskresensk Mineral Fertilisers, OJSC in Voskresensk, Moscow region.

Some of the information in this press release may contain projections or other forward-looking statements regarding future events or the future financial performance of URALCHEM. We wish to caution you that these statements are only predictions. We do not intend to update these statements and our actual results may differ materially from those contained in our projections or forward-looking statements, including, among others, the achievement of anticipated levels of profitability, growth, cost and synergy of our recent acquisitions, the impact of competitive pricing, the ability to obtain necessary regulatory approvals and licenses, the impact of developments in the Russian economic, political and legal environment, financial risk management and the impact of general business and global economic conditions.

Business

URALCHEM sets a record in Russia for the production of Ammonia

Leave a comment

URALCHEM set an absolute record in 2013 for the highest output of ammonia in Russia, with the total output of 2.819 million tonnes. Compared with 2012, production grew by 1.3%. The market situation in the ammonia segment of the global fertilizer market allowed the company to steadily follow its general production strategy.

Moscow, Russia (February 5, 2014) — URALCHEM set an absolute record in 2013 for the highest output of ammonia in Russia, with the total output of 2.819 million tonnes. Compared with 2012, production grew by 1.3%. The increased production was achieved through stable work of the units during the year, the implementation of projects to increase daily production at the units in the group’s enterprises in the Perm region and in Kirovo-Chepetsk, as well as through shortening repair down-time. The market situation in the ammonia segment of the global fertilizer market allowed the company to steadily follow its general production strategy.

URALCHEM’s production of major commodity products in 2013 comprised 6.039 million tonnes, 0.3% higher than a year earlier. Production of ammonium nitrate and its derivatives was 2.789 million tonnes, an increase by 7% compared to the same period last year. Monitoring the market situation, the company adjusted its production to the existing demand. Production of ammonia was decreased by 3% to 768 thousand tonnes. Urea production decreased by 2% to 1.138 million tonnes. Production of compound fertilizers decreased by 5%, to 581 thousand tonnes. Production of phosphate fertilizers (MAP / DAP) decreased by 13%, to 433 thousand tonnes.

Dmitry Konyaev, CEO of URALCHEM, OJSC, commented on the results, “In 2013 URALCHEM cemented its leadership of the nitrogen segment. It retained first place in Russia for the production of ammonia and ammonium nitrate, and the second in the production of urea. At the same time, an unfavourable situation for manufacturers in the global fertilizer market has reduced the output of certain products, primarily phosphorus fertilizers. In difficult market conditions, URALCHEM showed its significant margin of safety and ability to develop. In 2013, we successfully completed our largest logistics project when we opened a terminal in Riga for transhipment of bulk fertilizers with the capacity of up to 2 million tonnes per year. We signed an agreement on cooperation with the world’s top developer and licensor of urea processes, Stamicarbon. At the end of 2013 we acquired a 19.99 % stake in Uralkali, which we see as a strategic investment in one of the most profitable and promising sectors of the fertilizer market.”

For more information, please visit the Company web site http://www.uralchem.com or use the following contact information:

PR Department
URALCHEM, OJSC
Tel: +7 (495) 721 89 89
Email: pr@uralchem.com
Web: http://www.uralchem.com

URALCHEM, OJSC is one of the largest producers of nitrogen and phosphate fertilisers in Russia and the CIS with production capacities of over 2.5 million tonnes of ammonium nitrate, 2.8 million tonnes of ammonia, 0.8 million tonnes of MAP and DAP, 0.8 million tonnes of complex fertilisers and 1.2 million tonnes of urea. URALCHEM, OJSC is the second largest ammonium nitrate producer in the world and number one in Russia, the second largest producer of nitrogen fertilisers in Russia. Key production assets of URALCHEM, OJSC include Azot Branch of URALCHEM, OJSC in Berezniki, Perm Region; OJSC Minudobrenia, Perm; MFP Kirovo-Chepetsk Chemical Works, OJSC Branch in Kirovo-Chepetsk, Kirov region; Voskresensk Mineral Fertilisers, OJSC in Voskresensk, Moscow region.

Some of the information in this press release may contain projections or other forward-looking statements regarding future events or the future financial performance of URALCHEM. We wish to caution you that these statements are only predictions. We do not intend to update these statements and our actual results may differ materially from those contained in our projections or forward-looking statements, including, among others, the achievement of anticipated levels of profitability, growth, cost and synergy of our recent acquisitions, the impact of competitive pricing, the ability to obtain necessary regulatory approvals and licenses, the impact of developments in the Russian economic, political and legal environment, financial risk management and the impact of general business and global economic conditions.

Business

URALCHEM HOLDING P.L.C. Reports IFRS Financial Results for the First Six Months of 2013

Leave a comment

URALCHEM HOLDING P.L.C. (hereinafter URALCHEM Holding or the Company), a Cypriot holding company of the URALCHEM Group (hereinafter the Group), one of the largest producers of nitrogen and phosphate fertilizers in Russia, announced its unaudited IFRS financial results for the first six months of 2013.

Moscow, Russia (August 19, 2013)

– Revenue increased to US $1,292 million, compared to US $1,261 million in H1 2012.
– Operating profit amounted to US $394 million, compared with US $410 million in H1 2012.
– Adjusted EBITDA comprised US $452 million, compared to US $462 million in H1 2012.
– Net profit amounted to US $253 million, compared with US $444 million in H1 2012*.

URALCHEM HOLDING P.L.C. (hereinafter URALCHEM Holding or the Company), a Cypriot holding company of the URALCHEM Group (hereinafter the Group), one of the largest producers of nitrogen and phosphate fertilizers in Russia, announced its unaudited IFRS financial results for the first six months of 2013.

Dmitry Konyaev, CEO of URALCHEM, OJSC (the Russian holding company of the Group), commented on the Company’s results in the first half of 2013, “The overall global market situation has been less favourable for fertilizer producers in 2013 compared to last year. This trend is very likely to continue in the second half of this year. Along with the continuing rise in the cost of raw materials, this situation creates conditions for the further decline in the financial performance of the leading manufacturers of mineral fertilizers. Thanks to its strategy, URALCHEM is continuing to hold a leading position in a number of financial and operational indicators. In the first half of 2013, URALCHEM maintained its sales volume at the level of the first half of 2012 and increased revenues by 2%. In addition, as a result of early repayment of loans to the amount of US $300 million we were able to reduce the Company’s debt to a record low of US $787 million, as well as to withdraw from collateral all of the Group’s property. Net debt currently amounts to US $676 million”.

Financial Results

Revenue for the first six months of 2013 grew to US $1,292 million, compared to US $1,261 million last year. Operating profit amounted to US $394 million, or 31% of the revenue, compared with the operating profit of US $410 million, or 32% of the revenue, in the first half of 2012. Net profit amounted to US $253 million, compared to US $444 million in the first six months of 2012.

During the first half of 2013, adjusted EBITDA reached US $452 million, compared to US $462 million in the first half of the year before, a decrease by 2%. The adjusted EBITDA margin for the first six months of 2013 comprised 35% of revenue compared with 37% of revenue for the same period in 2012.

The main difference in the dynamics of the net profit compared to the other results is due to the fact that the results in 2012 included the revaluation of the Company’s share in Minudobrenia, Perm.

Markets

During the first half of the year, the price of ammonia was declining. The main factor determining the price dynamics was the lack of demand in the agricultural and the industrial segments. Lower demand in the agricultural segment was due to the late start of the sowing season in the Northern Hemisphere. Lack of demand in the industrial segment was caused by reduced production of phosphate fertilizers in North Africa and India.

Urea prices showed significant growth in the beginning of the year due to active procurement in Europe and North America, which coincided with a limited supply of product from Egypt, forcing buyers to look for alternative sources. However, from mid-February to the end of June prices have been decreasing, mainly due to lack of demand. In Europe and the US slowdown in demand was attributed to the late start of the sowing season. Latin American importers were putting off purchases, monitoring the changes in the situation. Additional pressure on prices was created by the accumulation of large stocks of products at Chinese ports, in anticipation of the period of low export duties, which began on 1 July.

During January and February there was a steady growth of quotations for ammonium nitrate. In mid-March, due to the pressure from urea prices, the trend changed. By mid-May, prices for ammonium nitrate decreased by $100/t, compared with the maximum prices registered in the middle of the first quarter. At the end of May, prices stabilized with repair works carried out at that time at CIS plants being one of the factors that contributed to this stabilization. By the end of the second quarter, prices in the CIS were supported by the industrial segment.

Until the middle of the first quarter, global decline in prices for phosphate fertilizers continued due to the lack of current demand. The decrease of production by major suppliers together with increased demand in Latin America stabilized prices. At the same time, Latin America remained the single largest source of demand. Indian buyers refrained from transactions. Since the beginning of the second quarter the decline was caused by the reduction of subsidies in India, the delays of purchases in the US domestic market due to the weather conditions, devaluation of currencies of major importing countries, such as Brazil and India, and policy of procurements to the current needs adopted by importers in other regions lead to oversupply in market and decrease in prices.

Production and sales

Volume of production by the Group’s plants increased by 1%, sales of commercial products of the Group remained virtually unchanged.

Financial Situation

Cash generated from operating activities in the first half of 2013 amounted to US $320 million, compared to US $342 million in the same period of 2012.

As at 30 June 2013, the Company’s net debt amounted to US $676 million. The weighted average interest rate of the loan portfolio in the first six months of 2013 equalled 4.7% annually compared to 5.2% annually during the same period in 2012.

For more information, please visit the Company web site http://www.uralchem.com or use the following contact information:

PR department
URALCHEM, OJSC
Tel: +7 (495) 721 89 89
E-Mail: pr@uralchem.com

URALCHEM HOLDING P.L.C. is a holding company of the URALCHEM Group, which includes four fertilizer manufacturing facilities in Russia. URALCHEM Group is one of the largest producers of nitrogen and phosphate fertilizers in Russia and the CIS with production capacities of over 2.5 million tons of ammonium nitrate, 2.8 million tons of ammonia, 0.8 million tons of MAP and DAP, 0.8 million tons of complex fertilizers and 1.2 million tons of urea per year. URALCHEM Group is the second largest ammonium nitrate producer in the world and number one in Russia, the second largest producer of nitrogen fertilizers in Russia. URALCHEM Group’s key production assets include Azot Branch of URALCHEM, OJSC in Berezniki, Perm Region; OJSC Minudobrenia, Perm; MFP Kirovo-Chepetsk Chemical Works, OJSC Branch in Kirovo-Chepetsk, Kirov region; Voskresensk Mineral Fertilizers, OJSC in Voskresensk, Moscow region.

Business

URALCHEM HOLDING P.L.C. Reports IFRS Financial Results for the First Quarter of 2013

Leave a comment

URALCHEM HOLDING P.L.C., a Cypriot holding company of the URALCHEM Group, one of the largest producers of nitrogen and phosphate fertilizers in Russia, announced its unaudited IFRS financial results for the first quarter of 2013.

Moscow, Russia (May 29, 2013)

– Revenue increased to US $683 million, compared to US $673 million in Q1 2012.
– Operating profit increased to US $220 million, compared with US $178 million in Q1 2012.
– Adjusted EBITDA grew to US $250 million, compared to US $207 million in Q1 2012.
– Net profit amounted to US $161 million, compared with US $354 million in Q1 2012*.

URALCHEM HOLDING P.L.C. (hereinafter URALCHEM Holding or the Company), a Cypriot holding company of the URALCHEM Group (hereinafter the Group), one of the largest producers of nitrogen and phosphate fertilizers in Russia, announced its unaudited IFRS financial results for the first quarter of 2013.

Dmitry Konyaev, CEO of URALCHEM, OJSC (the Russian holding company of the Group), commented on the results, “In the first quarter of this year, URALCHEM increased its revenues and the adjusted EBITDA grew substantially. This shows how effectively the Company is working. URALCHEM is still focusing on production of high-margin products demanded by the market. The first three months of 2013 showed the sort of results which we had anticipated. This is a positive testament to our strategy of strengthening our position in the nitrogen segment.”

Financial Results

Revenue for the first quarter of 2013 grew to US $683 million, compared to US $673 million in the first quarter of last year. Operating profit amounted to US $220 million, or 32% of the revenue, compared with the operating profit of US $178 million, or 26% of the revenue, in the first quarter of 2012. Net profit for the first quarter of 2013 amounted to US $161 million, compared to US $354 million in the first quarter of 2012.

During the first quarter of 2013, adjusted EBITDA reached US $250 million, compared to US $207 million the year before, a rise of 19%. The adjusted EBITDA margin for the first quarter of 2013 comprised 37% of revenue compared with 31% of revenue for the first quarter of 2012.

Revenue, EBITDA margin and adjusted EBITDA increased during the first quarter of 2013 as compared to the same period in 2012. The difference in the net profit is due to revaluation of the Company’s share in Minudobrenia, Perm carried out in 2012 and foreign exchange differences that showed opposite dynamics in 2013.

Markets

Ammonia
During the quarter, the price of ammonia was slowly declining. The main factor determining the price dynamics was the lack of demand in both the agricultural and the industrial segments. Reduced production of phosphate fertilizers in North Africa and India resulted in lower demand for ammonia in these regions. US demand for ammonia for direct application was satisfied by supplies from Trinidad and from domestic market. The growth of the industrial segment in East Asia appeared to be insufficient to cover spot volumes and the demand was met by contract supplies. Ammonia production in Egypt decreased due to the limitations of gas supplies for nitrogen production, but at the same time, capacities utilization in Trinidad increased to 90%.

Urea
At the beginning of the quarter prices for urea increased rapidly. Quotes for prilled urea in the Black Sea ports showed growth from $375/t FOB in early January to $445/t FOB in mid-February. In the Baltic, the corresponding figures were at $360/t FOB and $430/t FOB. The most significant factor that determined the dynamics of prices at the beginning of the first quarter was the shift of the market balance towards demand.

On the one hand, the early part of the year is traditionally a period of high demand from Europe and the USA, and European importers had low stocks at the start of the purchasing season. On the other hand, restrictions on the supply of gas to nitrogen production facilities in Egypt at the beginning of the year led to a substantial reduction in export supply.

Shortages of supply of Egyptian urea increased the interest of European buyers in products from other countries, including the supply of prilled urea from the CIS. However, from mid-February, there was a reduction in prices, which continued until the end of the quarter. In the ports of CIS, price reduction was associated with the sale of long positions by traders. A decline in prices for ammonium nitrate in Europe produced additional pressure on the price of urea.

Prices continued to decline in March due to lower demand in the US and Europe, caused by the delay in fertilizer application due to adverse weather conditions. Latin American importers, the biggest buyers of Russian urea, switched to purchasing for current needs, focusing on the dynamics of prices. Toward the end of March, supply increased in the Ukrainian ports in connection with the completion of the season in that area.

Ammonium nitrate
Quotes for ammonium nitrate generally followed the trends in the price of urea. During January and February there was a steady growth in the quotations for the product at the ports of the CIS because of the shortage of the product available for export, due to supplies being allocated for domestic use. In mid-March the trend changed markedly due to lower domestic demand.

Phosphate fertilizers
Until mid-February, global decline in prices continued due to the lack of current demand. In February, major suppliers decreased production, which made it possible to stabilize prices. Then, due to increased demand in Latin America, prices started to restore. By the end of March, indicators of export prices in Tampa rose to $515/t FOB against the lowest prices of $465/t – $475/t FOB. Still, Latin America remained the single largest source of demand. Indian buyers refrained from transactions; closed tenders were held, mostly to test price expectations.

Production and sales

In the first quarter of 2013 the fertilizer market was stable and the Group’s products enjoyed strong demand. Volume of production by the Group’s enterprises remained at the level of the first quarter of last year. A significant portion of production output was sold in April 2013 due to adverse weather conditions and late start of the sowing season.

Financial Situation

Cash generated from operating activities in the first quarter of 2013 amounted to US $168 million, compared to US $174 million in the first quarter of 2012.

As at 31 March 2013, the Company’s net debt amounted to US $801 million. The weighted average interest rate of the loan portfolio in the first quarter of 2013 equalled 4.6% annually compared to 5.8% annually during the same period last year.

-Ends-

For more information, please visit the Company web site http://www.uralchem.com or use the following contact information:

PR department
URALCHEM, OJSC
Tel: +7 (495) 721 89 89
E-Mail: pr@uralchem.com

URALCHEM HOLDING P.L.C. is a holding company of the URALCHEM Group, which includes four fertilizer manufacturing facilities in Russia. URALCHEM Group is one of the largest producers of nitrogen and phosphate fertilizers in Russia and the CIS with production capacities of over 2.5 million tons of ammonium nitrate, 2.8 million tons of ammonia, 0.8 million tons of MAP and DAP, 0.8 million tons of complex fertilizers and 1.2 million tons of urea per year. URALCHEM Group is the second largest ammonium nitrate producer in the world and number one in Russia, the second largest producer of nitrogen fertilizers in Russia. URALCHEM Group’s key production assets include Azot Branch of URALCHEM, OJSC in Berezniki, Perm Region; OJSC Minudobrenia, Perm; MFP Kirovo-Chepetsk Chemical Works, OJSC Branch in Kirovo-Chepetsk, Kirov region; Voskresensk Mineral Fertilizers, OJSC in Voskresensk, Moscow region.

Business

URALCHEM HOLDING P.L.C. Reports IFRS Financial Results for the year 2012

Leave a comment

– Revenue increased to US $ 2,423 million, compared to US $ 2,080 million in 2011.
– Operating profit increased to US $ 734 million, compared with US $ 659 million in 2011.
– Adjusted EBITDA grew to US $ 839 million, compared to US $ 750 million in 2011.
– Net profit amounted to US $ 665 million, compared with US $ 445 million in 2011.

Moscow, Russia (March 12, 2013) — URALCHEM HOLDING P.L.C. (hereinafter URALCHEM Holding or the Company), a Cypriot holding company of the URALCHEM Group (hereinafter the Group), one of the largest producers of nitrogen and phosphate fertilizers in Russia, published its audited IFRS Financial Statements for the year 2012.

Dmitry Konyaev, CEO of URALCHEM, OJSC (a Russian holding company of the Group), commented on the 2012 results, “Thanks to the programmes for the modernization of production facilities, which we have successfully implemented in recent years, as well as our efforts to improve the management of the company, the year 2012 was a success for URALCHEM Holding. During the year, we maintained an optimal balance of production, oriented towards current demand, which allowed us to be responsive to the needs of the market. These factors enabled the company to show good operational and financial performance over the past year.”

Financial Results

Revenue for the year 2012 grew to US $ 2,423 million, compared to US $ 2,080 million in 2011. Operating profit amounted to US $ 734 million, or 30% of the revenue, compared with the operating profit of US $ 659 million, or 32% of the revenue in 2011. Net profit for the year 2012 amounted to US $ 665, compared to US $ 445 million in 2011.

During the year 2012, adjusted EBITDA reached US $839 million, compared to US $750 million the year before, a rise of 12%. Adjusted EBITDA margin for the year 2012 comprised 35% of the revenue compared with 36% of the revenue for the year 2011.

Markets

After the fall of the price of ammonia in the first quarter due to lower demand from industrial consumers, prices started to recover in late March and early April. This recovery occurred due to the delayed launch of new facilities and close-down repairs at a number of major enterprises in the Middle East, as well as restrictions on the supply of gas in Trinidad. The same factors determined growth in prices during the second and third quarters. In the fourth quarter, there was a decline in prices associated with the reduction in demand from the industrial consumers in the US, Asia, and North Africa. Over the year, average prices for ammonia on the basis of FOB Yuzhny port grew by 5.2% compared to the same period in 2011.

The urea market remained relatively stable in the first half of the first quarter. However, a sharp rise in prices began later, due to high demand in the United States, backed by demand in Latin America and India. In the second half of the second quarter, prices fell due to the end of seasonal demand in the Northern Hemisphere. During the third quarter, prices were relatively stable, with a tendency to growth towards the end of the quarter, due to increased demand in major markets, which coincided with the closure of a number of CIS and the Middle East facilities for repairs. In the fourth quarter, prices fell due to low buying activity. Overall, in the second half of the year the market was under pressure from massive Chinese exports. As a result, the average price of prilled urea on the basis of FOB Yuzhny port decreased by 3.5% compared to 2011.

The prices of ammonium nitrate in 2012 basically followed the dynamics of the urea price. The price increase in the first quarter was driven by demand in the domestic market of the CIS. Until the middle of the second quarter, prices grew mainly due to the support from price of urea. From the middle of the second quarter, prices fell under the influence of the seasonal decrease in demand and also the pressure of prices for urea. In the third quarter, prices were relatively stable. Near the end of the quarter there was a strong growth in prices due to the lack of available products as a result of a number of enterprises switching to the production of commercial ammonia, as well as due to increased demand in the domestic market of the CIS. Falling prices in the first half of the fourth quarter is associated with pressure from the price of urea. From the middle of the quarter, there was a recovery in prices for ammonium nitrate in the ports of the CIS because of redistribution of the product to the domestic market, as well as switching of production to the manufacture of ammonia. Overall for the year 2012, there was a 2% decline in the prices of ammonium nitrate in the ports of CIS compared to the average price in 2011.

During the first quarter, the price of phosphate fertilizers slightly decreased due to the extremely low market activity. In the second quarter, the signing of the Indian contracts stabilized prices. During the quarter, the market showed a moderate recovery due to demand in Latin America and a number of “niche” markets. The third quarter was characterized by stable prices and low market activity. By the end of the quarter there was a tendency to a slight decrease in prices due to lack of demand in the South Asian markets and the purchasing tactics used by Latin American buyers based on current needs. In the fourth quarter, the downward trend in prices continued. The main reason for the decline in prices remained a lack of demand from South Asia, the low demand activity in Latin America, as well as increasing export supply from the US due to the end of the phosphate season. In 2012 the price of phosphate fertilizers in the CIS ports decreased by more than 12% compared to the average price in 2011.

Sales

Against the background of steady high demand for the Group’s fertilizers in Russia and abroad, the sales in 2012 rose by 18% compared to 2011, amounting to a total of 5,796 thousand tons. Sales of urea increased by 128%, sales of commercial ammonia grew by 50%.

Financial Situation

Due to the increase in revenue, cash generated from operating activities amounted to US $669 million for the year 2012, compared to US $523 million the year before.

On 31 December 2012, the Company’s net debt amounted to US $830 million compared to US $931 million at the end of the previous year. The weighted average interest rate in the loan portfolio of the Group for the year 2012 amounted to 5.2% annually compared to 5.9% annually for the year 2011.

-Ends-

For more information, please visit the Company web site http://www.uralchem.com or use the following contact information:

PR department
URALCHEM, OJSC
Tel: +7 (495) 721 89 89
E-Mail: pr@uralchem.com

URALCHEM HOLDING P.L.C. is a holding company of the URALCHEM Group, which includes four fertilizer manufacturing facilities in Russia. URALCHEM Group is one of the largest producers of nitrogen and phosphate fertilizers in Russia and the CIS with production capacities of over 2.5 million tons of ammonium nitrate, 2.8 million tons of ammonia, 0.8 million tons of MAP and DAP, 0.8 million tons of complex fertilizers and 1.2 million tons of urea per year. URALCHEM Group is the second largest ammonium nitrate producer in the world and number one in Russia, the second largest producer of nitrogen fertilizers in Russia. URALCHEM Group’s key production assets include Azot Branch of URALCHEM, OJSC in Berezniki, Perm Region; OJSC Minudobrenia, Perm; MFP Kirovo-Chepetsk Chemical Works, OJSC Branch in Kirovo-Chepetsk, Kirov region; Voskresensk Mineral Fertilizers, OJSC in Voskresensk, Moscow region.

Business

URALCHEM HOLDING P.L.C. Reports the First Nine Months of Year 2012 Unaudited IFRS Financial Results

Leave a comment

URALCHEM HOLDING P.L.C. announced its unaudited IFRS financial results for the first nine months of 2012 ending 30 September 2012.

(Moscow, Russia – November 16, 2012) – Revenue increased to US $1,804 million, compared to US $1,556 million in the first nine months of 2011.
– Operating profit increased to US $553 million, compared to US $487 million in the first nine months of 2011.
– Adjusted EBITDA grew to US $632 million, compared to US $560 million in the first nine months of 2011.
– Net profit amounted to US $600 million, compared to US $318 million in the first nine months of 2011.

URALCHEM HOLDING P.L.C. (hereinafter URALCHEM HOLDING or the Company), a Cypriot holding company of the URALCHEM Group (hereinafter called the Group), one of the largest producers of nitrogen and phosphate fertilisers in Russia, announced its unaudited IFRS financial results for the first nine months of 2012 ending 30 September 2012.

Dmitry Konyaev, CEO of URALCHEM, OJSC (part of the Group), commented on the results for the first nine months of 2012: “During nine months of this year the Company showed steady improvement of its financial performance compared to the results for the same period of 2011. To this contributed the acquisition earlier this year of another production unit, Minudobrenia, located in Perm and rising world prices for our main products, ammonia and urea. Looking back at the first nine months, we are optimistic about the full-year results for 2012.”

Financial Results

Revenue in the first nine months of 2012 grew to US $1,804 million, compared to US $1,556 million in the first nine months of 2011. Operating profit amounted to US $553 million compared with operating profit of US $487 million in the first nine months of 2011. Operating profit margin amounted to 31% both in the first nine months of 2012 and in the same period of the previous year.

In the first nine months of 2012, net profit amounted to US $600 million, compared with US $318 million in the same period in 2011.

In the first nine months of 2012 adjusted EBITDA reached US $632 million compared to US $560 million for the same period last year, an increase of 13%. Adjusted EBITDA margin in the first nine months of 2012 comprised 35%, compared with 36% in the first nine months of 2011.

Markets

During the third quarter of 2012, price dynamics for fertilizers and intermediate products were different.

Prices for ammonia in the third quarter showed a significant increase due to growing demand and limited supply. During these three months, the price level rose by $50 / t, and reached $650 / t FOB Port of Yuzhny by the end of September.

In the absence of a strongly marked trend, the urea market was characterized by high volatility. Prices have not shown any significant increase or noticeable reduction, remaining within the limits of $360 to $400 / t FOB the ports of the CIS.

Ammonium nitrate prices mainly matched the dynamics of urea prices during the third quarter.

The global market for phosphate fertilizers in the third quarter of 2012 showed low levels of activity. In September, there has been a downward trend in prices amid a lack of demand in South Asia (India, Pakistan).

Sales

As the demand for the Group’s products both in Russia and abroad was high and stable, the volume of sales in the first nine months of 2012 increased by 16% compared to the same period in 2011 and totalled 4,357 thousand tonnes for all products. Sales of urea, increased by 144%, largely contributed to the rise. Due to high demand in the ammonia market, sales of ammonia increased by 54%, while sales of ammonium nitrate decreased by 6%. Sales of “other chemicals” increased by 19%, mainly due to increased sales of ammonium nitrate for industrial use in the domestic market.

Financial Situation

Increased revenues contributed to the increase of cash generated from operations to US $472 million in the first nine months of 2012 rise, compared to US $330 million in the same period last year.

As at September 30, 2012 the Company’s net debt amounted to US $945 million. The weighted average interest rate in the loan portfolio during the first nine months of 2012 comprised 5.8% per annum compared to 7.9% in the same period last year.

For more information, please visit the company web site http://www.uralchem.com or use the following contact information:

PR department
URALCHEM, OJSC
Tel: +7 (495) 721 89 89
E-Mail: pr@uralchem.com

URALCHEM HOLDING P.L.C. is a holding company of the URALCHEM Group, which includes four fertilizer manufacturing facilities in Russia. URALCHEM Group is one of the largest producers of nitrogen and phosphate fertilisers in Russia and the CIS with production capacities of over 2.5 million tons of ammonium nitrate, 2.8 million tons of ammonia, 0.8 million tons of MAP and DAP, 0.8 million tons of complex fertilisers and 1.2 million tons of urea per year. URALCHEM Group is the second largest ammonium nitrate producer in the world and number one in Russia, the second largest producer of nitrogen fertilisers in Russia. URALCHEM Group’s key production assets include Azot Branch of URALCHEM, OJSC in Berezniki, Perm Region; OJSC Minudobrenia, Perm; MFP Kirovo-Chepetsk Chemical Works, OJSC, Kirovo-Chepetsk, Kirov region; Voskresensk Mineral Fertilisers, OJSC in Voskresensk, Moscow region.

Business

Pavel Gagarin Diagnoses the Medical Market in Russia as looking very Healthy for Investors

Leave a comment

In late September 2012, Pavel Gagarin, Chairman of the Board of Gradient Alpha Investments Group, explained to the participants of the third all-Russia medical forum in Moscow the ways of attracting investments into medical establishments.

Moscow, Russia (October 5, 2012) — In late September 2012, Pavel Gagarin, Chairman of the Board of Gradient Alpha Investments Group, explained to the participants of the third all-Russia medical forum in Moscow the ways of attracting investments into medical establishments.

The need for quality health care in Russia is huge, with most people believing that they can only get it for money. According to a survey carried out by Romir Holding this summer, 67% of Russians have used paid medical services in the last year. More than half of the respondents paid their own account and 15% used those services as part of their corporate or private health insurance schemes.

Russian commercial medicine is one of the fastest growing industries in the country. From 2007 to 2011 the market volume has grown from 367 to 535 billion roubles (from £7.3 bn to £10.7 bn). The annual growth, even during the crisis, has remained at a level of 16%. Outpatient services comprise half of this market, laboratory-diagnostic services take one-quarter, a 16% share of the market is taken by in-patient treatment and 8% by rehabilitation services.

67% of Russians, when using paid medical services, turn to private health care institutions; 46% of patients go to state clinics and hospitals (13% use both). Among the five most popular services customers prefer to pay for are: dentistry, gynaecology, therapy (GP), ophthalmology and medical anaesthetics. Only 23% of those who do not use paid medicine believe that they cannot afford it; the others either claim to be completely healthy or are happy with the free medicine provided by the state.

The second factor that makes the market for private medical services in Russia promising and attractive to private capital is of the state policies for the privatization of medical institutions. In accordance with the Federal Law of 08.05.2010, No.83-FZ “On Amendments to Certain Legislative Acts of the Russian Federation in connection with the improvement of the legal status of state (municipal) institutions”, many hospitals that have received autonomous status will be incorporated and transferred to the management of private parties. Tax incentives, such as corporation tax will also contribute to the growth of investment. Thus, within the framework of the Russian health reform, the state is gradually but purposefully substituting its operational functions by controlling functions.

Gradient Alpha’s experience in supporting investment projects in the health area and auditing health facilities shows that competent management can increase the revenues of a medical institution by 30% to 50%. This fact is not a secret to the authorities who are willing to pass health care facilities to private owners in exchange for shares in the business of these companies.

A vivid example of such a transaction is the April 2012 deal between the Moscow government and the Medsi group of companies. Under this project, the city authorities passed two state-owned sanatoriums, three hospitals and five out-patient clinics in Moscow, as well as one resort in the Crimea to Russia’s largest private network of health care institutions in exchange for a 25% share of the new company. Using these medical institutions, Medsi is launching new, specialized centres providing high-tech services. Thanks to the administrative resources that it has acquired through this transaction, the network of clinics is expecting to acquire the state quota for such services. The well-known American fund Apax Partners and the Russian Direct Investment Fund have signed an agreement to invest about $200 million in the development of this project.

Therefore, Russian health care is an attractive area for investors. Despite long investment horizons and difficulties in obtaining permits, the vast growth potential of the market provides for very good opportunities in terms of future income.

-Ends-

For more information, please visit the company web site http://www.gradient-alpha.biz or use the following contacts:

PR department
Gradient Alpha Investments Group
Tel: +7 (495) 740 1264
E-Mail: m.shetilenko@gradient-alpha.ru

PR representative in Europe
Eva Smit
Tel: +44 (0) 7538 978986
E-Mail: insidersuk@gmail.com

Gradient Alpha Investments Group has more than 15 years of experience in facilitating investment deals in Russia. Acting as a strategic growth consultant for many Russian companies, the group has conducted hundreds of investment projects, both private and public, in various sectors of the economy. The total amount of investment capital procured through Gradient Alpha has averaged around three billion US dollars per year during the last five years.

Business

Battle-Hardened Investors give their View on the Russian Market

Leave a comment

The meetings took place in France (February 23, Paris), USA (12-14 March, New York), UK (12 April, London), Germany (15 May, Munich) and Russia (22 May, Moscow).

Moscow, Russia (July 4, 2012) — (For Immediate Release)
– Innovative technologies are the most attractive industry sector in Russia for foreign investors.
– Russian manufacturing and industry interest investors much more than investments in land and property.
– Foreign investors in Russia tend to invest relatively small capital (less than 1 million euros) in several projects and get returns within one to two years.
– The most popular form of investment project in Russia is a joint venture with a Russian co-investor or the “receiver of the investment”.
– Despite difficulties, Moscow remains the most attractive region for investment.
– Within the hierarchy of investment risks in Russia, investors continue to worry most about tax and administrative risks.

These were the main conclusions reached by Russian consulting group Gradient Alfa, which were based on surveys among businessmen and investors who participated at meetings held by the company in the first half of 2012. The meetings took place in France (February 23, Paris), USA (12-14 March, New York), UK (12 April, London), Germany (15 May, Munich) and Russia (22 May, Moscow).

Chairman of the Board of Directors of Gradient Alpha, Pavel Gagarin, said that foreign investors view the Russian market as attractive and promising, although they place it in the “higher risk zone”. It is the potential to minimize these risks that determines the attractiveness of investment projects.

“The last thing foreign investors want to invest in is land and property, even in Moscow and the Moscow region; it is incomprehensible and scary for them. By comparison, manufacturing and industry appear a lot more attractive. Despite Russia’s entry into the WTO, the “import replacement” policy of the Russian authorities is actively continuing. To bypass these restrictions, investors need to start their production inside Russia, opening branches and representative offices here. Moreover, it is easier to start a new business from scratch in the Special Economic Zones, than to revive an old company, which is burdened with debts and other obligations,” said Pavel Gagarin.

Surveys conducted by Gradient Alpha show that innovative technology is currently by far the most attractive investment sphere in Russia. This is mainly due to the insignificant level of investment required and the quick returns. Besides, the choice is driven by the high demand from Russian consumers for these products. The good prospects for this market are highlighted by the rapid growth and penetration of traditional and mobile Internet; there has also been a sharp increase in the number of mobile applications.

The next most promising areas for investors are retail and certain sectors of the FMCG market. Network retail is viewed as particularly attractive. Consumption in Russia is very high. Leading national retailers increase revenue by more than 30% annually. According to the Association of Retail Companies, retail networks comprise 38% of the Russian retail sector, with the five largest companies having 10% market share.

Another trend for foreign investors is to invest relatively small sums of capital (less than 1 million euros) in several projects and to get returns within one to two years. The most popular form of investment project is a joint venture with a co-investor or the receiver of the investment. For investors, who would be perfectly capable of financing the whole project, this is a way to diversify risks. It is safer to invest 30% of the available resources in three different projects than to fund 100% of one project.

Despite the fact that Moscow is a difficult city in which to do business, it is still the most attractive investment region. “Investors are afraid to invest in projects located more than 50 kilometres from the capital for the following reason: it can be easier to work in the regions, but that depends entirely on the specific attitude of the authorities’ representatives there. There is no such dependence on the “human factor” in the federal centre, rather a dependence on the system, which is easier to adapt to,” said Pavel Gagarin.

Another Russian region selected by investors as an attractive area for investment is Tatarstan. In addition to a favourable investment climate, this choice is determined by a simplified procedure for businesses and property registration, the vast territories of the republic and the availability of cheap labour.

Today, foreign investors have a certain perception of investment risks in Russia and their relative importance. In the first place are tax risks, meaning rather a possibility of unfair taxation than a high level of taxes. The second and third places are bureaucratic and administrative risks that might affect the time taken to receive the required permits, constantly changing terms for them and regular changes to the “rules of the game.” Fourth place is taken by legal risks. Foreign investors see the legal environment for doing business in Russia as “legal chaos”. By this they are referring to discrepancies between federal and local laws, lack of uniformity in law enforcement and the absence of federal laws “On Public-Private Partnership”, “On Holding Companies” and “On project financing.”

For more information, please visit the company web site http://www.gradient-alpha.biz or use the following contact information:

PR department
Gradient Alpha Investments Group
Tel: +7 (495) 740 1264
E-Mail: m.shetilenko@gradient-alpha.ru

PR representative in Europe
Eva Smit
Tel: +44 (0) 7538 978986
E-Mail: insidersuk@gmail.com

Gradient Alpha Investments Group has more than 15 years of experience in facilitating investment deals in Russia. Acting as a strategic growth consultant for many Russian companies, the group has conducted hundreds of investment projects, both private and public, in various sectors of the economy. The total amount of investment capital procured through Gradient Alpha has averaged around three billion US dollars per year during the last five years.

Business

URALCHEM HOLDING P.L.C. Reports IFRS Financial Results for the First Quarter of 2012

Leave a comment

URALCHEM HOLDING P.L.C. announced its unaudited IFRS financial results for the first quarter of 2012 ending 31 March 2012.

Moscow, Russia – May 31, 2012 — (For Immediate Release)

– Revenue increased to US $673 million, compared to US $566 million in Q1 2011.
– Operating profit increased to US $178 million, compared with US $160 million in Q1 2011.
– Adjusted EBITDA grew to US $207 million, compared to US $186 million in Q1 2011.
– Net profit amounted to US $354 million, compared with US $174 million in Q1 2011.

URALCHEM HOLDING P.L.C. (hereinafter URALCHEM Holding or the Company), a Cypriot holding company of the URALCHEM Group (hereinafter the Group), one of the largest producers of nitrogen and phosphate fertilizers in Russia, announced its unaudited IFRS financial results for the first quarter of 2012 ending 31 March 2012.

Dmitry Konyaev, CEO of URALCHEM, OJSC (part of the Group), commented on the first quarter of 2012 results, “I am pleased with the Company’s results in the first quarter of this year. We are moving ahead as planned. Net profit in the first quarter of 2012 more than doubled compared to the same period last year. This happened due to the acquisition of Minudobrenia in Perm, as well as the reassessment of our share in the enterprise. Besides, the net profit figure was influenced by a considerable reduction in interest expenses on loans which became possible after we refinanced the loan portfolio last year.”

Financial Results

Revenue for the first quarter of 2012 grew 19% to US $673 million, compared to US $566 million in the first quarter of 2011. Operating profit amounted to US $178 million, or 26% of the revenue, compared with the operating profit of US $160 million, or 28% of the revenue in the first quarter of 2011.

Net profit for the first quarter of 2012 more than doubled, amounting to US $354 million, compared to US $174 million in the first quarter of 2011. Without the reassessment of the Company’s share in Minudobrenia, Perm the net profit growth comprised 15%.

During the first quarter of 2012, adjusted EBITDA reached US $207 million, compared to US $186 million the year before, a rise of 11%. Adjusted EBITDA margin for the first quarter of 2012 comprised 31% of revenue compared with 33% of revenue for the first quarter of 2011.

Markets

In the first quarter of 2012 the prices of fertilizers and intermediates showed significantly different dynamics. Prices for ammonia at the Yuzhny port fell to $70 / t due to low demand, both in agriculture and industry, which coincided with the launch of Qafco V. Market recovery began only in late March.

During January to early February the urea market repeated its dynamics in 2011. However, in mid-February a rapid increase in the price of urea started due to high demand in the U.S. The late Q1/early Q2 price level approached peak figures ??of 2011 even surpassing them at certain markets. Prospects for market development in the second quarter remain optimistic for market participants.

Prices for ammonium nitrate were stable during the first quarter due to high volumes of domestic market shipments.

The global market of phosphate fertilizers in the first quarter of 2012 was characterized by low activity, with prices going down slightly. European demand was limited due to severe weather conditions and financial instability. Moderate recovery in prices occurred in late Q1 due to higher demand in Latin America and the U.S. domestic market.

Sales

In the first quarter of 2012 the Group’s product sales amounted to 1.7 million tons, up 20% compared to the first quarter of 2011. Through the acquisition of OJSC Minudobrenia, Perm in January 2012, sales of urea and of ammonia increased significantly.

Financial Situation

Cash generated from operating activities grew by 4%, from US $167 million in the first quarter of 2011 to US $174 million in the first quarter of 2012.

On 31 March 2012, the Company’s net debt amounted to US $1,076 million. The weighted average interest rate in the loan portfolio for the first quarter 2012 decreased to 5.85% compared to annual 8.0% for the same period last year.

Annex to the press release about the unaudited financial results for the first quarter of 2012

EBITDA is a profit / loss from financial and economic activities during the reporting period, before deduction of income tax on profits, income and interest costs, depreciation and amortization. “Adjusted EBITDA” is EBITDA for the reporting period before goodwill, profit / loss from associates, profit / loss on foreign exchange differences arising on financial performance and profit / loss on operations with derivative financial instruments. Adjusted EBITDA is operating profit before depreciation and amortization and financial results of operations with derivative financial instruments. In accordance with International Financial Reporting Standards (“IFRS”), depreciation and amortization are included in cost structure, and in the selling, general and administrative expenses. IFRS does not require the disclosure and does not describe the calculation of EBITDA and adjusted EBITDA, among other financial indicators, so they can not substitute for net profit for the period when evaluating the results of operations or the measure of cash provided by operating activities when evaluating liquidity. Approach to the calculation of EBITDA and adjusted EBITDA, as described earlier, may not coincide with the approaches used by other companies, therefore, comparability may be limited. We believe that EBITDA and adjusted EBITDA provide useful information to investors because they are indicators of the stability and efficiency of our business and our ability to fund discretionary spending such as capital expenditures, the acquisition of subsidiaries and other investments, as well as indicators of our ability to incur and service debt. IFRS classifies depreciation and amortization to operating costs, while in fact they are distributed to the current period non-cash expenses for the acquisition or creation of fixed assets, incurred in previous periods, and are not affiliated with the movement of funds.

For more information, please visit the Company web site http://www.uralchem.com or use the following contact information:

PR department
URALCHEM, OJSC
Tel: +7 (495) 721 89 89
E-Mail: pr@uralchem.com

Business

URALCHEM Achieved Record Financial and Operating Results in 2011

Leave a comment

URALCHEM HOLDING P.L.C. Reports IFRS Financial Results for the year ended 31 December 2011.

Moscow, Russia – March 26, 2012 — URALCHEM HOLDING P.L.C. (hereinafter URALCHEM Holding or the Company), a Cypriot holding company of the URALCHEM Group (hereinafter the Group), one of the largest producers of nitrogen and phosphate fertilizers in Russia, announced its audited IFRS financial results for the year ended 31 December 2011.

Dmitry Konyaev, CEO of URALCHEM, OJSC (a Russian holding company of the Group), commented on the 2011 results: “With the favorable market conditions in 2011 the Group achieved record financial and operating results. The volume of marketable production reached 5 million tons, which is in excess of the planned figures. The acquisition of Minudobrenia, Perm will strengthen the Group’s position in the nitrogen segment and will allow it to produce 18% to 20% of domestic urea. Thus, URALCHEM can now become the second largest urea producer in Russia.”

Financial Results

Revenue for the year 2011 grew to US $ 2,080 million, compared to US $ 1,389 million in 2010. Operating profit amounted to US $ 661 million, or 32% of the revenue, compared with the operating profit of US $ 205 million, or 15% of the revenue in 2010. Profit for the year amounted to US $ 445 in 2011, compared to US $ 35 million in 2010.

During the year ended 31 December 2011, adjusted EBITDA reached US $ 752 million, compared to US $ 309 million the year before, a rise of 143%. Adjusted EBITDA margin for the year 2011 comprised 36% of revenue compared with 22% of revenue for the year ended 31 December 2010.

Markets

The urea market dynamics during the period January to September 2011 were significantly different compared to the same period in 2010; the traditional weakening of the market in the 1st quarter was replaced by a sharp rise in prices, which continued throughout the 2nd quarter and amounted to almost $ 200 / t. Then, after a brief downward correction, prices were restored and stabilized in the range of $ 480 – $ 500 / t FOB Yuzhny port. The main reason for the sharp rise in prices was the imbalance between limited supply and the strong demand from the markets in Asia, Latin America and Africa. In the 4th quarter there was a seasonal slump in prices. The situation was determined by high levels of stocks by traders and producers, as well as by the suppliers’ desire to sell their long positions before the Christmas and New Year holidays.

The ammonium nitrate market during the first half of the year basically repeated the dynamics of urea market. However, during the third quarter, because of the effect of lower demand in all major markets, the prices of ammonium nitrate significantly decreased – back to the level of the beginning of the year. During August – September there were price fluctuations within the range of $ 310 – $ 330 / t FOB CIS. In the fourth quarter the decline in prices for ammonium nitrate was mainly due to pressure from the price of urea.

Since the beginning of 2011, the global market of phosphorus fertilizers was characterized by stable shortages that arose due to the decrease in supply from major sources. Prices increased steadily and in September 2011 reached the level that exceeded the same period the year before by 33%. Large volumes of imports of phosphate fertilizers to South Asia and Latin America during the period from the first to the third quarter 2011 allowed large amounts of stocks to accumulate, which led to the decrease in prices in the fourth quarter.

The NPK market in 2011 basically repeated the dynamics of phosphates.

Sales

Against the background of steady high demand for mineral fertilizers in Russia and abroad for most of 2011, the Group’s sales rose by 7% compared to 2010, amounting to a total of 4,920 thousand tons. Sales of urea increased by 18%, sales of phosphate fertilizers grew by 10%. Sales of “other chemicals” increased by 55% due to the increase of sales of ammonium nitrate for industrial use, as well as launch of export sales of new products.

Financial Situation

Due to the increase in revenue, cash generated from operating activities amounted to US $ 525 million for the year ended 31 December 2011, compared to US $ 135 million for the same period the year before.

On 31 December 2011, the Company’s net debt[2] amounted to US $ 930.8 million. The weighted average interest rate in the loan portfolio for the year ended 31 December 2011 amounted to 6.35% compared to 9.07% for the year ended 31 December 2010.

-Ends-

For more information, please visit the Company web site http://www.uralchem.com or use the following contact information:

PR department
URALCHEM, OJSC
Tel +7 (495) 721 89 89
pr@uralchem.com

URALCHEM HOLDING P.L.C. is a holding company of the URALCHEM Group, which includes four fertilizer manufacturing facilities in Russia. URALCHEM Group is one of the largest producers of nitrogen and phosphate fertilizers in Russia and the CIS with production capacities of over 2.5 million tons of ammonium nitrate, 2.8 million tons of ammonia, 0.8 million tons of MAP and DAP, 0.8 million tons of complex fertilizers and 1.2 million tons of urea. URALCHEM Group is the second largest ammonium nitrate producer in the world and number one in Russia, the second largest producer of nitrogen fertilizers in Russia. URALCHEM Group’s key production assets include Azot Branch of URALCHEM, OJSC in Berezniki, Perm Region; OJSC Minudobrenia, Perm; MFP Kirovo-Chepetsk Chemical Works, OJSC Branch in Kirovo-Chepetsk, Kirov region; Voskresensk Mineral Fertilizers, OJSC in Voskresensk, Moscow region.